Last reviewed · How we verify

NCT06696781

NOL Index in Response to Pacemaker Stimulation

Completed Last updated 11 August 2025
What this trial tests

trial testing Pacemaker stimulation in Nociceptive Pain in 20 participants. Completed in 1 July 2025.

Timeline
18 November 2024
Primary endpoint
1 June 2025
1 July 2025

Quick facts

Lead sponsorInstitutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date18 November 2024
Primary completion1 June 2025
Estimated completion1 July 2025
Sites1 location across Romania

Drugs / interventions tested

Conditions studied

Sponsor

Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu

Who can join

Adults 18 to 80, any sex, with Nociceptive Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Nociception Level Index (NOL Index) utilizes various signals to assess the balance of nociception and antinociception during anesthesia. Its correlation with nociceptive stimuli and opioids is known, but its response to isolated heart rate changes remains uncertain. The aim is to investigate how cardiac pacing affects the NOL Index.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Nociception level index response to pacemaker stimulation.
    Balan C, Barbulescu RT, Dumitrache A, Fodoroiu A, et al · · 2025 · PMID 41182599 · DOI 10.1007/s10877-025-01377-w

Verify or expand the search:

Other recruiting trials for Nociceptive Pain

Currently open trials in the same condition.

Other Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06696781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing